Neuropace shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $38k | 2.5k | 15.44 |
| 2025-09-30 | $25k | 2.5k | 10.31 |
| 2025-06-30 | $27k | 2.5k | 11.14 |
| 2025-03-31 | $16k | 1.3k | 12.29 |
| 2024-12-31 | $15k | 1.3k | 11.19 |
| 2024-09-30 | $9.3k | 1.3k | 6.97 |
| 2024-06-30 | $10k | 1.3k | 7.56 |
| 2022-03-31 | $4.0k | 546 | 7.33 |
| 2021-12-31 | $6.0k | 546 | 10.99 |
| 2021-09-30 | $9.0k | 546 | 16.48 |
| 2021-06-30 | $13k | 546 | 23.81 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors